# PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation

Study · id `cardio:ct-nct03996772` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03996772](<https://clinicaltrials.gov/study/NCT03996772>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03996772

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 319 participants.

## Technical summary

Registry record NCT03996772. Randomized; single masking; primary purpose prevention. Start 2019-06-03 (actual); primary completion 2024-05-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 319 participants (enrolled count; ClinicalTrials.gov record NCT03996772, source copy `cardio:ctgov-nct03996772-2025-01-13`, retrieved 2026-10-26)
- Started: 2019-06-03 (actual) (ClinicalTrials.gov record NCT03996772, source copy `cardio:ctgov-nct03996772-2025-01-13`, retrieved 2026-10-26)
- Primary completion: 2024-05-31 (actual) (ClinicalTrials.gov record NCT03996772, source copy `cardio:ctgov-nct03996772-2025-01-13`, retrieved 2026-10-26)
- Completion: 2024-05-31 (actual) (ClinicalTrials.gov record NCT03996772, source copy `cardio:ctgov-nct03996772-2025-01-13`, retrieved 2026-10-26)
- Countries: Austria; France; Germany; Italy; Spain; United Kingdom (ClinicalTrials.gov record NCT03996772, source copy `cardio:ctgov-nct03996772-2025-01-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03996772-2025-01-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation
- Acronym: PRESTIGE-AF
- Condition: Atrial Fibrillation
- Condition: Intracerebral Hemorrhage
- Intervention (Drug): Apixaban Oral Tablet
- Intervention (Drug): Dabigatran
- Intervention (Drug): Edoxaban Tablets
- Intervention (Drug): Rivaroxaban
- Lead sponsor: Imperial College London
- Lead sponsor class: OTHER
- Collaborator: Wuerzburg University Hospital
- Collaborator class: OTHER
- Collaborator: Julius-Maximilians University
- Collaborator class: OTHER
- Collaborator: Medical University of Graz
- Collaborator class: OTHER
- Collaborator: University of Liverpool
- Collaborator class: OTHER
- Collaborator: King's College London
- Collaborator class: OTHER
- Collaborator: Hospital Universitari Vall d'Hebron Research Institute
- Collaborator class: OTHER
- Collaborator: University of Bordeaux
- Collaborator class: OTHER
- Collaborator: Azienda Ospedaliera di Perugia
- Collaborator class: OTHER
- Collaborator: Aalborg University
- Collaborator class: OTHER
- Collaborator: STROKE ALLIANCE FOR EUROPE
- Collaborator class: UNKNOWN
- Collaborator: University Hospital Heidelberg
- Collaborator class: OTHER
- Collaborator: Imperial College Healthcare NHS Trust
- Collaborator class: OTHER
- Collaborator: Alfried Krupp Krankenhaus
- Collaborator class: OTHER
- Collaborator: University Hospital, Bordeaux
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry intervention name matches this record: Dabigatran (`cardio:dabigatran`)
- Registry intervention name matches this record: Rivaroxaban (`cardio:rivaroxaban`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial (`cardio:pubmed-40023176`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Neuroimaging Markers Associated With Recurrent Stroke in Intracerebral Hemorrhage and Atrial Fibrillation: Secondary Analysis of PRESTIGE-AF (`cardio:pubmed-41197104`)

Courtesy of the U.S. National Library of Medicine.

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 11 registry organizations

## Provenance

Content hash: 075f7606befa9eab26c5094366a5af8254d6c389765716dfe18acd6867f3df5b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
